PeptidePicker
Get Started
Home/Peptides/PT-141
Sexual HealthFDA Approved

PT-141

Also known as: Bremelanotide · Vyleesi

An FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder. Unlike Viagra, PT-141 acts on the central nervous system to induce arousal rather than relying on blood flow.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~2.7 hours

Typical Dose

1.75 mg

Administration

Subcutaneous injection

Mechanism of Action

Activates MC3R and MC4R melanocortin receptors in the hypothalamus to stimulate sexual desire through central nervous system pathways.

Key Research Areas

sexual healthlibidoFDA approvedmelanocortin

Frequently Asked Questions

What is PT-141?▾
An FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder. Unlike Viagra, PT-141 acts on the central nervous system to induce arousal rather than relying on blood flow.
How does PT-141 work?▾
Activates MC3R and MC4R melanocortin receptors in the hypothalamus to stimulate sexual desire through central nervous system pathways.
What is the recommended dosage for PT-141?▾
The typical research dosage is 1.75 mg, administered via Subcutaneous injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of PT-141?▾
The half-life of PT-141 is approximately ~2.7 hours. This affects dosing frequency and timing in research protocols.
Is PT-141 FDA approved?▾
Yes, PT-141 is FDA approved for specific medical indications. Consult your physician for proper medical guidance.

Research Disclaimer

The information provided about PT-141 is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Sexual Health

Kisspeptin

KISS-1 · Metastin

Back to All PeptidesFind Your Peptide — Take the Quiz